Phase I Pharmacokinetic Study (BF-BLOCK)

NCT01423305 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Orion Corporation, Orion Pharma